NASDAQ:ALRN
Aileron Therapeutics Inc Stock News
$3.90
+0.0200 (+0.515%)
At Close: May 14, 2024
Aileron Therapeutics Is Pleased to Outline Strategy to Strengthen Phase 1b Clinical Trial of ALRN-6924 in Patients with p53-Mutated Breast Cancer
11:51am, Monday, 01'st Aug 2022 GlobeNewswire Inc.
BOSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more pati
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
04:11pm, Friday, 15'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Ce
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022
12:31pm, Friday, 08'th Jul 2022 GlobeNewswire Inc.
BOSTON, July 08, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more pati
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
08:52am, Friday, 01'st Jul 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phas
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
08:55am, Thursday, 30'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offerin
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
04:32pm, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Brickell Biotech, Inc. (NASD
BOSTON, June 29, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more pati
Aileron Therapeutics Announces First Patients Treated in Phase 1b Trial of ALRN-6924 in Patients with p53-Mutated Neoadjuvant Breast Cancer
11:00am, Thursday, 19'th May 2022 GlobeNewswire Inc.
BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
3 Oversold Biotech Stocks to Buy Now
06:40am, Thursday, 19'th May 2022
Looking for oversold biotech stocks? These three have all seen significant drops this year despite promising catalysts for the future.
Aileron Therapeutics to Present at the H.C. Wainwright Global Investment Conference
07:00am, Tuesday, 17'th May 2022
BOSTON, May 17, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patient
Aileron Therapeutics to Host Virtual KOL Investor Event on May 19, 2022
11:00am, Friday, 13'th May 2022 GlobeNewswire Inc.
BOSTON, May 13, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
Aileron Therapeutics Announces Late-Breaking Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at Upcoming Society for Investigative Dermatology 2022 Annual Meeting
04:43pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
BOSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
Aileron Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
08:15pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
Is Aileron Therapeutics (ALRN) Outperforming Other Medical Stocks This Year?
11:19am, Thursday, 21'st Apr 2022
Here is how Aileron Therapeutics, Inc. (ALRN) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
Is Aileron Therapeutics, Inc. (ALRN) Stock Outpacing Its Medical Peers This Year?
01:40pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Here is how Aileron Therapeutics, Inc. (ALRN) and Becton Dickinson (BDX) have performed compared to their sector so far this year.